The University of Texas School of Medicine at San Antonio | ||
City: San Antonio | State: TX | |
Links:
Updates: This institution's COI policies were evaluated on Oct-17 -2016. This institution submitted policies for review for the 2016 AMSA Scorecard. |
Gifts | Gifts are allowed if less than $50. This is more than AMSA's $10 limit. They follow the sunshine act. However, in 13b it states (section a in policy) that clinicians (students included) or researchers may not accept any form of personal gift from industry [Domain Location: 13d, pg 1 (statement on gifts <$50), 13b, pg 3 for statement on no gifts.] |
|
Meals | Meals funded directly on or off campus are prohibited. No mention of food/meals for CME courses. [Domain Location: 13b, pg 3] |
|
Industry-funded promotional speaking relationships (not ACCME-accredited) | There is no specific mention of promotional speaking relationships/bureaus. Only general mentions of divorcing clinical care decisions from any perceived or actual benefits accrued. The closes thing is that clinicians may not receive compensation or parti [Domain Location: 13b, pg 4] |
|
Industry-support of ACCME-accredited CME | Promotional material is prohibited. Content is controlled by speaker and the AMC. Attendees are not compensated and no gifts are accepted. Funds are provided to the school/division and not individual - they are specific on this. [Domain Location: 13e pg 7-8 was comprehensive in outlining specifics that satisfy criteria; 13h, but no mention of industry-support, and whether it is prohibited. 13b pg 4] |
|
Attendance of industry-sponsored promotional events | Faculty are allowed to go - but prohibited from receiving gifts/compensation. They need to be unbiased and all speakers need to disclose their relationships at said program. [Domain Location: 13f, pg 10] |
|
Industry-supported scholarships and awards | Funds are accepted if it is received by the school and not an individual. Additionally, the school will select the recipient of the funds and not the industry donor. [Domain Location: 13k, pg 5] |
|
Ghostwriting and honorary authorships | Clinicians or researchers may not participate in or receive compensation for papers or speeches that were ghostwritten by individuals employed or retained by industry; [Domain Location: 13b pg 4] |
|
Consulting and advising relationships | Clinician or researcher may accept only fair market compensation for specific, legitimate services provided by him or her to industry. Payment must commensurate with time and effort. The terms of the arrangements, services provided, and compensation must [Domain Location: 13b pg 3] |
|
Access of pharmaceutical sales representatives | section k. 'Reps not allowed in patient care areas. Exceptions are permitted when there is a clear educational or patient care benefit, for example demonstration of a patient procedure requiring technical support by industry personnel. However, access to [Domain Location: 13k, pg 5] |
|
Access of medical device representatives | Reps definition include medical device reps. See Domain 9. They're allowed in patient care areas only for legitimate reasons not related to marketing. They have restrictions regarding their activities and access to patients as well. [Domain Location: 13k, pg 5] |
|
Conflict of interest disclosure | Satisfies our criteria. Internal/external disclosure. [Domain Location: 13k, pg 11] |
|
COI curriculum | Curriculum is for residents and students. It is part of their panel discussions in 'medicine, behavior, and society' course along with their 'team care' course. However, in looking at the curriculum, they do not mention understanding effects of influence [Domain Location: 13z, pg 1, 13m, pg 1-2] |
|
Extension of COI policies to community affiliates | It applies to all affiliate hospitals that trainees may rotate through. [Domain Location: 13z, pg 1] |
|
Enforcement and Sanctions of Policies | There is an oversight committee and disciplinary action reference at the last page of the main policy-holding documents. [Domain Location: 13b, pg 12; 13k, pg 11] |
Model policy | |
Good progress toward model policy | |
No policy, or policy unlikely to have a substantial effect on behavior |